Polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors

London

Roots Analysis has announced the addition of “Polycystic Ovary Syndrome Market, 2021-2031” report to its list of offerings.

Currently, there is no cure for polycystic ovary syndrome (PCOS / PCOD), however the affiliated symptoms can be treated using a combination of different types of medications, including insulin-sensitizing agents, oral contraceptives, anti-androgens and anti-obesity drugs. The research activities, including clinical investigations in this domain are being driven by both industry and non-industry players.

To order this 90+ page report, which features 70+ figures, please visit https://www.rootsanalysis.com/reports/polycystic-ovarian-syndrome-market.html

Leave a Reply

Your email address will not be published. Required fields are marked *